Patents by Inventor Deanna Byrne

Deanna Byrne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5403825
    Abstract: Described is a purified osteogenic factor that when delivered to bone in association with a physiologically acceptable delivery vehicle is capable of inducing new bone growth at the bone surface. The osteogenic factor is water soluble, and is characterized physically by a molecular weight of about 2.5 kD when measured by gel filtration under dissociating conditions and an isoelectric point in the pH range from about 4.6 to 7.2. Use of the purified factor in treating bone defects is described. Also described is a method for obtaining the purified factor from mammalian bone.
    Type: Grant
    Filed: September 1, 1992
    Date of Patent: April 4, 1995
    Assignee: Allelix Biopharmaceuticals Inc.
    Inventors: Alain E. Lagarde, Abdulwahid Abdulwajid, Donna Bueschkens, Deanna Byrne
  • Patent number: 5169837
    Abstract: Described is a purified osteogenic factor that when delivered to bone in association with a physiologically acceptable delivery vehicle is capable of inducing new bone growth at the bone surface. The osteogenic factor is water soluble, and is characterized physically by a molecular weight of about 2.5 kD when measured by gel filtration under dissociating conditions and an isoelectric point in the pH range from about 4.6 to 7.2. Use of the purified factor in treating bone defects is described. Also described is a method for obtaining the purified factor from mammalian bone.
    Type: Grant
    Filed: March 28, 1991
    Date of Patent: December 8, 1992
    Assignees: Allelix Biopharmaceuticals Inc., Glaxo Canada Inc.
    Inventors: Alain E. Lagarde, Abdulwahid Abdulwajid, Donna Bueschkens, Deanna Byrne